Current Clinical Trials
Department: Oncology
Diagnosis: Hematology- Lymphoma
Principal Investigator: O'Brien M.D., Edward Thomas
Sub-Investigator(s):
Sponsor: Pfizer
Indentifier #: NCT01232556
Title: B1931008, An Open-Label, Randomized, Phase 3 Study Of Inotuzumab Ozogamicin Administered In Combination With Rituximab Compared To Defined Investigator's Choice Therapy In Subjects With Relapsed Or Refractory CD22-Positive Aggressive Non-Hodgkin Lymphoma Who Are Not Candidates For Intensive High-Dose Chemotherapy
Department: Oncology
Diagnosis: Oncology - General
Principal Investigator: Lynch MD, Cynthia A.
Sub-Investigator(s):
Sponsor: Tesaro
Indentifier #: NCT01500226
Title: TS-P04834, A Phase 3, Multicenter, Randomized, Double Blind, Active-Controlled Study of the Safety and Efficacy of Rolapitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Subjects Receiving Moderately Emetogenic Chemotherapy (MEC)
Department: Cardiology
Diagnosis: Cardiac - Device
Principal Investigator: Deshmukh MD FACC MRCP, Pramod
Sub-Investigator(s):
Sponsor: St. Jude Medical
Indentifier #: NCT01528150
Title: Accent MRI Pacemaker and Tendril MRI Lead IDE Study
Department: Cardiology
Diagnosis: Cardiac - Coronary Artery Disease
Principal Investigator: Sporn M.D., Daniel
Sub-Investigator(s):
Sponsor: DCRI
Indentifier #: NCT00786474
Title: "Bridging Anticoagulation in Patients who Require Temporary Interruption of Warfarin Therapy for an Elective Invasive Procedure or Surgery (BRIDGE) Trial"
Department: Family Practice
Diagnosis: Infectious Disease
Principal Investigator:
Sub-Investigator(s):
Sponsor: Pfizer
Indentifier #: NCT00665561
Title: An International, Multicenter, Prospective Observational Study Of The Safety Of Maraviroc Used With Optimized Background Therapy In Treatment-Experienced HIV-1 Infected Patients